191 related articles for article (PubMed ID: 37258470)
1. Comprehensive Analysis of Prognostic Value and Immune Infiltration of Src Family Kinases in Hepatocellular Carcinoma.
Yao D; Deng Y; Zhang S; Liang L; Zhang L; Weng S; Chen S
Front Biosci (Landmark Ed); 2023 May; 28(5):90. PubMed ID: 37258470
[TBL] [Abstract][Full Text] [Related]
2. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion.
Je DW; O YM; Ji YG; Cho Y; Lee DH
Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma.
Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q
BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238
[TBL] [Abstract][Full Text] [Related]
4. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
5. LncRNA DBH-AS1 facilitates the tumorigenesis of hepatocellular carcinoma by targeting miR-138 via FAK/Src/ERK pathway.
Bao J; Chen X; Hou Y; Kang G; Li Q; Xu Y
Biomed Pharmacother; 2018 Nov; 107():824-833. PubMed ID: 30142544
[TBL] [Abstract][Full Text] [Related]
6. Identification of prognostic biomarkers and correlations with immune infiltrates among cGAS-STING in hepatocellular carcinoma.
Qi Z; Yan F; Chen D; Xing W; Li Q; Zeng W; Bi B; Xie J
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33006365
[TBL] [Abstract][Full Text] [Related]
7. Cyclin-dependent kinase 19 upregulation correlates with an unfavorable prognosis in hepatocellular carcinoma.
Cai X; Deng J; Zhou J; Cai H; Chen Z
BMC Gastroenterol; 2021 Oct; 21(1):377. PubMed ID: 34649520
[TBL] [Abstract][Full Text] [Related]
8. Src family kinases differentially influence glioma growth and motility.
Lewis-Tuffin LJ; Feathers R; Hari P; Durand N; Li Z; Rodriguez FJ; Bakken K; Carlson B; Schroeder M; Sarkaria JN; Anastasiadis PZ
Mol Oncol; 2015 Nov; 9(9):1783-98. PubMed ID: 26105207
[TBL] [Abstract][Full Text] [Related]
9. Identification and activation of Src family kinases in primary megakaryocytes.
Lannutti BJ; Shim MH; Blake N; Reems JA; Drachman JG
Exp Hematol; 2003 Dec; 31(12):1268-74. PubMed ID: 14662334
[TBL] [Abstract][Full Text] [Related]
10. MARCKS on Tumor-Associated Macrophages is Correlated with Immune Infiltrates and Poor Prognosis in Hepatocellular Carcinoma.
Ren X; Ju Y; Wang C; Wei R; Sun H; Zhang Q
Cancer Invest; 2021 Oct; 39(9):756-768. PubMed ID: 34279157
[TBL] [Abstract][Full Text] [Related]
11. Identification of chloride intracellular channels as prognostic factors correlated with immune infiltration in hepatocellular carcinoma using bioinformatics analysis.
Huang JJ; Lin J; Chen X; Zhu W
Medicine (Baltimore); 2021 Nov; 100(45):e27739. PubMed ID: 34766585
[TBL] [Abstract][Full Text] [Related]
12. Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth.
Yan Y; Chen Y; Pan J; Xing W; Li Q; Wang Y; Gei L; Yuan Y; Xie J; Zeng W; Chen D
BMC Cancer; 2022 Dec; 22(1):1248. PubMed ID: 36456906
[TBL] [Abstract][Full Text] [Related]
13. PPM1D is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma.
Yu Z; Song Y; Cai M; Jiang B; Zhang Z; Wang L; Jiang Y; Zou L; Liu X; Yu N; Mao X; Peng C; Liu S
Aging (Albany NY); 2021 Sep; 13(17):21294-21308. PubMed ID: 34470916
[TBL] [Abstract][Full Text] [Related]
14. COL4A1 promotes the growth and metastasis of hepatocellular carcinoma cells by activating FAK-Src signaling.
Wang T; Jin H; Hu J; Li X; Ruan H; Xu H; Wei L; Dong W; Teng F; Gu J; Qin W; Luo X; Hao Y
J Exp Clin Cancer Res; 2020 Aug; 39(1):148. PubMed ID: 32746865
[TBL] [Abstract][Full Text] [Related]
15. Src heterodimerically activates Lyn or Fyn to serve as targets for the diagnosis and treatment of esophageal squamous cell carcinoma.
Zhang J; Zhao D; Zhang L; Xiao Y; Wu Q; Wang Y; Chen J; Zhan Q
Sci China Life Sci; 2023 Jun; 66(6):1245-1263. PubMed ID: 36763244
[TBL] [Abstract][Full Text] [Related]
16. CD97 serves as a novel biomarker of immune cell infiltration in hepatocellular carcinoma.
Su Q; Li L; Li X; Li W; Zhang X; Dong Y; Han L; Wang D; Ran J
World J Surg Oncol; 2022 Dec; 20(1):382. PubMed ID: 36464675
[TBL] [Abstract][Full Text] [Related]
17. CCT4 suppression inhibits tumor growth in hepatocellular carcinoma by interacting with Cdc20.
Li F; Liu CS; Wu P; Ling AS; Pan Q; Li XN
Chin Med J (Engl); 2021 Nov; 134(22):2721-2729. PubMed ID: 34732665
[TBL] [Abstract][Full Text] [Related]
18. Six Cell Cycle-related Genes Serve as Potential Prognostic Biomarkers and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.
Shi Y; Sang X; Deng J; Wang Y; Chen X; Lin S; Wu F; Xu A
J Cancer; 2023; 14(1):9-23. PubMed ID: 36605491
[No Abstract] [Full Text] [Related]
19.
Liu S; Zhao W; Li X; Zhang L; Gao Y; Peng Q; Du C; Jiang N
Front Oncol; 2021; 11():713017. PubMed ID: 34595113
[TBL] [Abstract][Full Text] [Related]
20. DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.
Song D; Wang Y; Zhu K; Tian L; Gao Q; Zhou J; Fan J; Wang X
World J Surg Oncol; 2020 Jul; 18(1):176. PubMed ID: 32690026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
